VAERS Explorer
Back to explore

Report #2870415

Received Nov 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
0.2 yrs
State
IN
Recovered
Unknown
Vaccinated
Oct 27, 2025
Onset
Oct 27, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPIPVHIBDTAP + IPV + HIB (PENTACEL)SANOFI PASTEURUNKUK344AAOT / LL

Symptoms (1)

Product preparation error

Symptom narrative

pentacel was reconstituted with a sterile diluent used w/ mmr and proquad (sterile water) with no reported ae; Initial information received on 28-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 month old female patient who was administered with Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine [Pentacel (VERO)] was reconstituted with a sterile diluent used w/ MMR and Proquad (sterile water) with no reported ae (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Immunoglobulin Antihepatitis B (Hepatitis B [Immunoglobulin Antihepatitis B]) For Immunisation; Pneumococcal Vaccine Conj 20v (Crm197) (Pneumococcal Vaccine Conj 20v (Crm197)) For Immunisation; And Rotavirus Vaccine (Rotavirus Vaccine) for Immunisation. On 27-Oct-2025, the patient received a 07ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine Suspension for injection (lot UK344AA, standard strength, frequency once and expiry date-31-Jan-2027) via intramuscular route in the left thigh for Immunization was reconstituted with a sterile diluent used w/ MMR and proquad (sterile water) with no reported ae (product preparation error) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other medications

HEPATITIS B [IMMUNOGLOBULIN ANTIHEPATITIS B]; PNEUMOCOCCAL VACCINE CONJ 20V (CRM197); ROTAVIRUS VACCINE